Mizuho Issues Positive Forecast for Cabot (NYSE:CBT) Stock Price

Cabot (NYSE:CBT) had its target price boosted by Mizuho from $72.00 to $80.00 in a research report sent to investors on Thursday, MarketBeat.com reports. The brokerage currently has an outperform rating on the specialty chemicals company’s stock.

Several other equities research analysts have also issued reports on CBT. JPMorgan Chase & Co. lowered their target price on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research note on Friday, November 28th. Zacks Research lowered shares of Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Wednesday, October 8th. Finally, UBS Group decreased their target price on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and an average target price of $66.33.

Cabot Stock Performance

CBT opened at $67.45 on Thursday. The firm has a market capitalization of $3.57 billion, a PE ratio of 11.22, a P/E/G ratio of 3.54 and a beta of 0.90. The firm has a 50 day moving average of $65.53 and a two-hundred day moving average of $73.09. Cabot has a 12-month low of $58.33 and a 12-month high of $96.39. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.50.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). The business had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. Cabot had a net margin of 8.91% and a return on equity of 24.55%. Cabot’s revenue for the quarter was down 10.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. On average, analysts anticipate that Cabot will post 7.57 EPS for the current year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Friday, November 28th were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.7%. Cabot’s payout ratio is currently 29.95%.

Institutional Trading of Cabot

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Nuveen LLC acquired a new stake in Cabot during the 1st quarter worth approximately $12,365,000. Russell Investments Group Ltd. raised its stake in shares of Cabot by 84.3% during the 1st quarter. Russell Investments Group Ltd. now owns 61,657 shares of the specialty chemicals company’s stock worth $5,126,000 after buying an additional 28,198 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Cabot by 8.2% during the first quarter. Dimensional Fund Advisors LP now owns 1,426,693 shares of the specialty chemicals company’s stock worth $118,606,000 after acquiring an additional 108,397 shares during the last quarter. Brooklyn Investment Group lifted its stake in Cabot by 1,553.7% in the 1st quarter. Brooklyn Investment Group now owns 678 shares of the specialty chemicals company’s stock valued at $56,000 after buying an additional 637 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its position in shares of Cabot by 204.9% in the first quarter. Hsbc Holdings PLC now owns 71,238 shares of the specialty chemicals company’s stock valued at $5,895,000 after acquiring an additional 47,871 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.